Outsourced Pharma Capacity Update | July 2023

07.20.2023

Kevin Yarnall, Sr. Manager, Manufacturing, presented Emergent's manufacturing capabilities and available capacity at its Rockville, Maryland drug product facility during the Outsourced Pharma Capacity Webinar in June. If you missed the live presentation, watch ondemand to learn how Emergent is equipped to support the scale-up and CGMP manufacturing for your next clinical or commercial therapy.

OPCU Webinar - JUN2023 - Cover Image

Emergent CDMO

Drug Product Fill/Finish Webinars

01.25.2021

Humanigen and Emergent BioSolutions Announce Contract Development and Manufacturing Agreement for Phase 3 COVID-19 Therapeutic Candidate Lenzilumab™

GAITHERSBURG, MD. and BURLINGAME, CA. – Jan. 25, 2021—Emergent BioSolutions Inc.(NYSE:EBS) (Emergent) andHumanigen, Inc....

10.27.2022

SAB Biotherapeutics Announces Exclusive Manufacturing Partnership with Emergent BioSolutions

SIOUX FALLS, S.D. and GAITHERSBURG, Md., Oct. 27, 2022 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS), ("SAB”), a...

08.30.2021

Utilizing Expertise & Experience for Successful Downstream Processing

Successful downstream processing provides isolation of the molecule of interest from extraneous constituents before formulation,...